Watkins Tim bought CTNM
January 30, 2026 · Form 4 insider transaction
Watkins Tim bought 160,000 shares of Contineum Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
160,000
Price
$0.00
Total value
N/A
InsiderWatkins Tim
Role—
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJanuary 30, 2026
Filing dateJanuary 30, 2026
Shares owned after160,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Options granted under the Issuer's 2024 Equity Incentive Plan. The options shares vest in equal monthly installments over 48 months, subject to the Reporting Person's continuous service.